title: Protein phosphatases 1 and 2A regulate the transcriptional and DNA binding activities of retinoic acid receptors.
abstract: To determine which factors may regulate the DNA binding and transcriptional properties of retinoic acid receptors (RARs and RXRs), we investigated the sensitivity of reporter genes bearing various retinoic acid response elements (RAREs) to protein phosphatases (PPases) inhibition. PPases inhibition by okadaic acid led to an increase of the reporter genes activity in a RARE-dependent and ligand-independent manner and was dependent on the type of response element used. Overexpression of protein phosphatases 2A and 1 (PP2A and PP1) decreased the inducibility of the reporter genes tested. Nuclear extracts from okadaic acid-treated COS cells displayed an 2-5-fold increased level of receptor binding to RAREs in vitro, suggesting that PPases inhibition increased the DNA binding activity of retinoid receptors. Treatment of receptors extracted from COS cells by alkaline phosphatase and partially purified PP1 and PP2A decreased their DNA binding activity, but heterodimers bound to DNA were not sensitive to phosphatase treatment. Reconstitution experiments showed that phosphorylation of both receptors increased the DNA binding activity of RXR/RAR heterodimers. Taken together, these data show that the modulation of the phosphorylation state of RARs and RXRs represents an other level of regulation of the retinoid signaling pathway.
authors.affiliation: CJF INSERM 92-03, Laboratoire de Biochimie Structurale Faculté de Médecine de Lille, France.
authors.forename: P
authors.initials: P
authors.lastname: Lefebvre
authors.forename: M P
authors.initials: MP
authors.lastname: Gaub
authors.forename: A
authors.initials: A
authors.lastname: Tahayato
authors.forename: C
authors.initials: C
authors.lastname: Rochette-Egly
authors.forename: P
authors.initials: P
authors.lastname: Formstecher
mesh_terms: D000818:Animals; D001483:Base Sequence; D002522:Chlorocebus aethiops; D004247:DNA / Q000378:metabolism; D004988:Ethers, Cyclic / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000378:metabolism; D019319:Okadaic Acid; D009838:Oligodeoxyribonucleotides / Q000737:chemistry / Q000378:metabolism; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000502:physiology*; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D018168:Receptors, Retinoic Acid / Q000378:metabolism*; D011994:Recombinant Proteins; D047488:Retinoid X Receptors; D014157:Transcription Factors / Q000378:metabolism*; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D004988:Ethers, Cyclic; D009687:Nuclear Proteins; D009838:Oligodeoxyribonucleotides; D018168:Receptors, Retinoic Acid; D011994:Recombinant Proteins; D047488:Retinoid X Receptors; D014157:Transcription Factors; D019319:Okadaic Acid; D004247:DNA; D010749:Phosphoprotein Phosphatases